Facts
- defined as headaches without an underlying structural or metabolic cause
- this is generally the territory of neurologists, however neurosurgical patients with actual mass lesions have all types of headaches and you are still responsible for teasing apart and diagnosing their headaches.
ㅤ | Tension | Migraine | Cluster |
Cause | muscle tension / central sensitization | abnormal excitability and signaling within pain / neuro-vascular pathways | posterior hypothalamic activation and trigeminal–autonomic reflex dysregulation. |
Location | dull-band like pressure around head, bilateral | unilateral | orbital/temporal pain, conjunctival injection, tearing, nasal congestion, facial/eyelid swelling, miosis or ptosis |
Duration | 30 min - several hrs | 4-72 hours | up to 180 min |
Change with activity | none | worsen | none |
Demographics | Slight F > M | Female > Male | 20-40 y.o. M |
Activity preference | quiet | Rest, dark quiet room | Restlessness, pacing |
Treatment | APAP / Motrin | see below | - 100% Oxygen - Sumatriptan 6 mg SC injection – most effective; relief in 5–10 min. - Zolmitriptan 5–10 mg nasal spray |
Cluster headaches are part of a broader class of Trigeminal Autonomic Cephalalgias (TACs) which are a group of severe unilateral headaches associated with cranial autonomic symptoms (tearing, rhinorrhea, ptosis, etc.) that include:
- Paroxysmal hemicrania – Shorter (2–30 min), more frequent, indomethacin-responsive.
- SUNCT/SUNA – Short-lasting unilateral neuralgiform headache with conjunctival injection/tearing (SUNCT) or autonomic symptoms (SUNA).
- Hemicrania continua – Continuous unilateral headache with exacerbations, also indomethacin-responsive.
Treatments
Mechanism | Drug Target |
CGRP release | CGRP antagonists (erenumab, fremanezumab) |
Serotonin modulation | Triptans (5-HT₁B/₁D agonists) |
Glutamate inhibition | Topiramate |
Ion channel stabilization | Valproate, beta-blockers |
Neurogenic inflammation reduction | NSAIDs, steroids |
Brainstem modulation | Amitriptyline, venlafaxine |